Using an aggressive breast cancer cell line, we made the discovery that ATOX1 accumulates at lamellipodia borders of migrating breast cancer cells and ATOX1 silencing resulted in migration defects as evidenced from reduced wound closure. This evidence concerns the gene ATOX1 and breast carcinoma.